Jump to content

Bevacizumab

From Simple English Wikipedia, the free encyclopedia

Bevacizumab is an anti-angiogenic drug that is used in the treatment of Metastatic Renal cell carcinoma, Metastatic breast cancer, Non-small cell lung cancer, and is also approved in the treatment Glioblastoma multiforme.[1]

References

[change | change source]
  1. ↑ "Bevacizumab Gets Fast-Track Approval for Glioblastoma". www.medpagetoday.com. 6 May 2009.
Retrieved from "https://simple.wikipedia.org/w/index.php?title=Bevacizumab&oldid=6439740"